Iovance Biotherapeutics (IOVA) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IOVA Stock Alerts $13.39 -0.59 (-4.22%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Iovance Biotherapeutics Short Interest DataCurrent Short Volume48,980,000 sharesPrevious Short Volume46,380,000 sharesChange Vs. Previous Month+5.61%Dollar Volume Sold Short$582.37 millionShort Interest Ratio / Days to Cover5.5Last Record DateApril 15, 2024Outstanding Shares279,830,000 sharesFloat Size220,710,000 sharesShort Percent of Float22.19%Today's Trading Volume4,195,241 sharesAverage Trading Volume8,061,181 sharesToday's Volume Vs. Average52% Short Selling Iovance Biotherapeutics ? Sign up to receive the latest short interest report for Iovance Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIOVA Short Interest Over TimeIOVA Days to Cover Over TimeIOVA Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Iovance Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202448,980,000 shares $582.37 million +5.6%22.2%5.5 $11.89 3/31/202446,380,000 shares $687.35 million -2.2%21.1%4.9 $14.82 3/15/202447,430,000 shares $659.75 million +1.5%21.6%4.6 $13.91 2/29/202446,710,000 shares $743.16 million +8.7%21.2%4.5 $15.91 2/15/202442,980,000 shares $424.21 million +2.4%20.1%4.4 $9.87 1/31/202441,970,000 shares $324.43 million -3.0%21.0%5.6 $7.73 Get the Latest News and Ratings for IOVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202443,270,000 shares $389.86 million +18.8%21.7%5.7 $9.01 12/31/202336,410,000 shares $296.01 million +3.2%18.2%4.8 $8.13 12/15/202335,280,000 shares $274.48 million +2.0%17.7%5.1 $7.78 11/30/202334,590,000 shares $209.96 million -2.8%17.5%4.7 $6.07 11/15/202335,590,000 shares $169.05 million -8.4%18.0%5.2 $4.75 10/31/202338,860,000 shares $148.45 million +0.3%19.4%6 $3.82 10/15/202338,740,000 shares $140.63 million +5.4%19.4%6.4 $3.63 9/30/202336,770,000 shares $167.30 million +20.5%18.4%6 $4.55 9/15/202330,510,000 shares $160.79 million +1.5%15.3%4.9 $5.27 8/31/202330,070,000 shares $181.62 million +9.2%14.7%6.2 $6.04 8/15/202327,530,000 shares $206.75 million -0.1%13.5%4.6 $7.51 7/31/202327,550,000 shares $200.01 million +6.1%13.6%4.6 $7.26 7/15/202325,960,000 shares $201.45 million -10.1%13.1%4.4 $7.76 6/30/202328,890,000 shares $203.39 million +12.8%14.6%5.1 $7.04 6/15/202325,620,000 shares $221.36 million +18.3%14.1%4.8 $8.64 5/31/202321,650,000 shares $189.22 million -7.4%11.9%4.4 $8.74 5/15/202323,380,000 shares $183.30 million No Change12.9%5.9 $7.84 10/31/202217,260,000 shares $161.21 million -5.0%12.2%8 $9.34 10/15/202218,170,000 shares $160.80 million -2.6%12.7%8.2 $8.85 9/30/202218,660,000 shares $178.76 million -4.5%13.0%8 $9.58 9/15/202219,540,000 shares $231.94 million -0.6%13.7%6.5 $11.87 8/31/202219,650,000 shares $210.65 million -5.4%13.7%5.6 $10.72 8/15/202220,760,000 shares $266.77 million +6.9%14.5%4.1 $12.85 7/31/202219,420,000 shares $226.24 million -2.6%14.0%3.8 $11.65 7/15/202219,940,000 shares $255.23 million -7.5%14.3%4.1 $12.80 6/30/202221,550,000 shares $237.91 million +30.1%15.5%4.4 $11.04 6/15/202216,560,000 shares $135.79 million -4.7%11.9%3.5 $8.20 5/31/202217,370,000 shares $117.25 million +1.0%12.5%4.6 $6.75 5/15/202217,200,000 shares $242.00 million +8.8%12.4%8.2 $14.07 4/30/202215,810,000 shares $239.52 million +3.7%11.4%7.7 $15.15 4/15/202215,250,000 shares $268.71 million +9.9%11.0%7.3 $17.62 3/31/202213,880,000 shares $231.10 million +1.5%N/A6.3 $16.65 3/15/202213,680,000 shares $171.14 million -0.3%9.9%6.7 $12.51 2/28/202213,720,000 shares $214.99 million +9.4%10.1%7 $15.67Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now IOVA Short Interest - Frequently Asked Questions What is Iovance Biotherapeutics' current short interest? Short interest is the volume of Iovance Biotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 48,980,000 shares of IOVA short. 22.19% of Iovance Biotherapeutics' shares are currently sold short. Learn More on Iovance Biotherapeutics' current short interest. What is a good short interest ratio for Iovance Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IOVA shares currently have a short interest ratio of 6.0. Learn More on Iovance Biotherapeutics's short interest ratio. Which institutional investors are shorting Iovance Biotherapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Iovance Biotherapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Iovance Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.19% of Iovance Biotherapeutics' floating shares are currently sold short. Is Iovance Biotherapeutics' short interest increasing or decreasing? Iovance Biotherapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 48,980,000 shares, an increase of 5.6% from the previous total of 46,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Iovance Biotherapeutics' float size? Iovance Biotherapeutics currently has issued a total of 279,830,000 shares. Some of Iovance Biotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Iovance Biotherapeutics currently has a public float of 220,710,000 shares. How does Iovance Biotherapeutics' short interest compare to its competitors? 22.19% of Iovance Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Iovance Biotherapeutics: SpringWorks Therapeutics, Inc. (14.23%), Immunocore Holdings plc (8.38%), Arcellx, Inc. (10.13%), Immunovant, Inc. (14.08%), Vericel Co. (9.36%), Krystal Biotech, Inc. (8.59%), Denali Therapeutics Inc. (8.33%), Apogee Therapeutics, Inc. (12.97%), CRISPR Therapeutics AG (17.37%), Kymera Therapeutics, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Iovance Biotherapeutics stock? Short selling IOVA is an investing strategy that aims to generate trading profit from Iovance Biotherapeutics as its price is falling. IOVA shares are trading down $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Iovance Biotherapeutics? A short squeeze for Iovance Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IOVA, which in turn drives the price of the stock up even further. How often is Iovance Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IOVA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SWTX Short Interest IMCR Short Interest ACLX Short Interest IMVT Short Interest VCEL Short Interest KRYS Short Interest DNLI Short Interest APGE Short Interest CRSP Short Interest KYMR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IOVA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings